ClinicalTrials.govpublic full text
Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD) and Non-interventional Arm With Untreated Patients
lca5, lca, retinal degeneration, ird, adeno associated virus, gene therapy, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 873942
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.